Eleotin Andramax Deux
Natural health product licensed in Canada
- Licence holder
- Eastwood Bio-Medical Research Inc.
- NPN or DIN-HM
- 80103264
- Status
- Active licence
- Licence date
- 4 August 2020
- Revision date
- Not provided
- Form
- Aérosol
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Huile de graine de Rubus Idaeus (Framboise), Huile de graine de carotte, Huile de Hippophae Rhamnoides, Parfum, Huile d'amandes douces
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | Not specified | Not specified |
Uses authorised in Canada
For reducing oversensitivity in advance of intercourse. For temporary male genital desensitisation, helping to slow the onset of ejaculation. For temporary male genital desensitisation to reduce oversensitivity in advance of intercourse and help slow the onset of ejaculation. Helps in temporarily retarding the onset of ejaculation/temporarily slowing the onset of ejaculation/temporarily prolonging the time until ejaculation. Helps in the prevention of premature ejaculation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Stop use and consult a health care practitioner/health care provider/health care professional/doctor/ physician if the following symptoms appear: weakness, confusion, headache, difficulty breathing and/or pale, gray or blue coloured skin. These symptoms may be signs of methemoglobinemia, a rare disorder, which may appear up to 2 hours after use.
Source
Official Health Canada record, licence 80103264
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.